RecruitingEarly Phase 1NCT06787560
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
Studying Syndrome with congenital neutropenia as a major feature
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Zhejiang University
- Principal Investigator
- He Huang, MDZhejiang University
- Intervention
- CD7 CAR-T cells injection(biological)
- Enrollment
- 20 enrolled
- Eligibility
- All sexes
- Timeline
- 2025 – 2028
Study locations (1)
- The first affiliated hospital of medical college of zhejiang university, Hangzhou, Zhejiang, China
Collaborators
Yake Biotechnology Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06787560 on ClinicalTrials.gov